Pluristem Therapeutics (NASDAQ:PSTI) Cut to Hold at Zacks Investment Research – Slater Sentinel
Pluristem Therapeutics (NASDAQ:PSTI) Cut to Hold at Zacks Investment Research Slater Sentinel
Source: Investment New Feed
Pluristem Therapeutics (NASDAQ:PSTI) Cut to Hold at Zacks Investment Research Slater Sentinel
Source: Investment New Feed